<?xml version="1.0" encoding="UTF-8"?>
<document id="30055288">
	<sentence id="s1" text="Aberrant expression of different family members of the Eph/ephrin system, which comprises the Eph receptors (Ephs) and their ligands (ephrins), has been implicated in various malignancies including breast cancer.">
		<entity id="s1.e1" charOffset="55-58"
			type="GENE" text="Eph" ontology_id="2041"/>
		<entity id="s1.e2" charOffset="205-211"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.">
		<entity id="s2.e1" charOffset="34-37"
			type="GENE" text="Eph" ontology_id="2041"/>
		<entity id="s2.e2" charOffset="81-87"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="88-101"
			type="HP" text="heterogeneity" ontology_id="HP_0001425"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="EphA2, EphB4 and EphB6 are the members most extensively studied in breast cancer.">
		<entity id="s3.e1" charOffset="0-3"
			type="GENE" text="Eph" ontology_id="2041"/>
		<entity id="s3.e2" charOffset="74-80"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Existing research points to the potential use of various Eph/ephrin members as biomarkers for assessing prognosis and selecting the most suitable therapeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast cancer heterogeneity">
		<entity id="s4.e1" charOffset="57-60"
			type="GENE" text="Eph" ontology_id="2041"/>
		<entity id="s4.e2" charOffset="259-265"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
</document>
